Russian HIV vaccine capable of generating antibodies - Vector Center
MOSCOW. Dec 18 (Interfax) - The human immunodeficiency virus (HIV) vaccine developed by the Vector State Research Center of Virology and Biotechnology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor) is capable of generating antibodies, which is proven by 100% of volunteers participating in phase 1 of clinical trials, Vector told Interfax on Friday. HIV-specific antibodies and cytotoxic T lymphocyte were detected in 100% of volunteers, while antibodies neutralizing HIV pseudo-viruses were found in the system of 80% of volunteers, Vector said.
Phase 1 of clinical trials of the CombiVICHvac vaccine was held in 2011, and confirmed that the vaccine is safe, does not have side-effects, and induces an HIV-specific humoral and cell response, it said
Russia registers 28,552 new Covid-19 cases, 611 deaths in past 24 hours - HQ
MOSCOW. Dec 18 (Interfax) - Russia registered 28,552 new Covid-19 cases and 611 coronavirus-related deaths in the past 24 hours, the coronavirus response headquarters said in a statement on Friday. Over the past day, 28,552 Covid-19 cases were confirmed in 85 regions of Russia, including 5,132 asymptomatic cases identified proactively (18.0%), the headquarters said.
Following a relative decline in morbidity, Russia has seen over 28,000 daily infections for two consecutive days. The number of deaths has been growing too, from 587 on Thursday to 611 on Friday. Russia hit the all-time high of 613 deaths on December 11.
The morbidity growth remains the steepest in Moscow. According to the headquarters, the Russian capital recorded 6,937 new Covid-19 cases, 72 deaths, and 5,821 recoveries over the past day.
Experts discuss consumer rights protection in EAEU, CIS
MINSK, 18 December (BelTA) - The 18th meeting of the CIS Advisory Council on Consumer Rights Protection was held at the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being (Rospotrebnadzor) on 17 December, BelTA learned from the Economic Cooperation Department at the CIS Executive Committee.
The meeting was attended by members of the advisory council from Belarus, Azerbaijan, Armenia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Uzbekistan, and representatives of the CIS Executive Committee, the Eurasian Economic Commission and public associations in the field of consumer rights protection of the CIS countries.
In India, mainstream environmentalism and development situate biodiversity conservation and human well-being as mutually exclusive goals. This is contentious because a large section of India’s population has inextricable economic, social, political, and cultural linkages with its rich biodiversity. The 4-Cs framework is suggested to address human well-being within the purview of ecosystem assessment and management by incorporating multiple social-ecological variables. Examples of domains, attributes, and indicators of human well-being are examined in the context of the Forest Rights Act (2006). Further, the framework can be tailor-made to guide conservation practitioners, establish the discourse on human well-being in the field of biodiversity science, and broaden the normative understanding of human well-being as an essential outcome of biodiversity conservation.
Where could the next pandemic and the tools to fight it come from? Scientists are studying bats
Updated Dec 17, 2020;
Posted Dec 17, 2020
A researcher for Brazil s state-run Fiocruz Institute takes an oral swab sample from a bat captured in the Atlantic Forest, at Pedra Branca state park, near Rio de Janeiro, Tuesday, Nov. 17, 2020.AP Photo/Silvia Izquierdo
Facebook Share
RIO DE JANEIRO (AP) Night began to fall in Rio de Janeiro’s Pedra Branca state park as four Brazilian scientists switched on their flashlights to traipse along a narrow trail of mud through dense rainforest. The researchers were on a mission: capture bats and help prevent the next global pandemic.